March 4 (Reuters) - The U.S. Food and DrugAdministration approved Eyenovia's ( EYEN ) eye drops to reduceinflammation and pain in patients who have undergone eyesurgery, Formosa Pharmaceuticals said on Monday.
Eyenovia ( EYEN ) acquired U.S. commercial rights of the drug inAugust last year from Formosa Pharmaceuticals.